Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sardinia Bioactives is an Italian biotechnology company specializing in the discovery and development of bioactive compounds sourced from the unique flora and marine life of Sardinia. As a spin-off from the University of Sassari, the company utilizes proprietary extraction technologies to isolate potent natural molecules with applications in the nutraceutical, cosmeceutical, and pharmaceutical sectors. Their research portfolio primarily targets oxidative stress, inflammation, and skin health, leveraging the chemical diversity of endemic Mediterranean species. The company provides high-quality, scientifically-backed ingredients and offers research services for the characterization of natural products. Sardinia Bioactives aims to translate regional biodiversity into innovative health solutions through rigorous academic validation and sustainable sourcing. By bridging the gap between laboratory research and industrial production, they support the development of next-generation wellness products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sardinia Bioactives.